@import url(http://drbillfoundation.org/pmwiki/pub/skins/sinorca/basic.css); @import url(http://drbillfoundation.org/pmwiki/pub/skins/sinorca/layout.css); @import url(http://drbillfoundation.org/pmwiki/pub/skins/sinorca/sinorca.css);
Today : Wed, 27 Aug 2008
View other Common Causes of Vision Impairment
Macular degeneration is a disease of the retina and is one of the leading causes of vision impairment in the world today. The retina is the light sensing tissue that lines the inside of the eye. It consists of millions of cells that absorb light and send information to the visual centers of the brain. The centermost region of the retina is called the macula and consists of cone cells that provide detailed sight, daylight vision, and color vision. The macula geographically accounts for less than 10 percent of the entire retina, similar to a “bull’s eye” on a dartboard. However, this small region of retina plays an extremely important role because it allows us to identify details and provides clear sight, stereoscopic depth perception, and distance vision. The remainder of the retina that surrounds the macula consists of rod cells which are responsible for night vision, and peripheral vision, but they do not have the ability to see details clearly.

Patients with macular degeneration tend to have blurred distance and near sight, sensitivity to glare and bright light, poor contrast vision, reduced stereoscopic depth perception, and they may have color vision problems. Their clarity of sight may range from 20/70 in the early stages but may worsen to 20/400 in the most advanced stages. Fortunately, patients with macular degeneration do not become totally blind because the condition only affects the macular region and does not affect the peripheral retina. Patients with macular degeneration tend to use their peripheral vision to perform visual tasks and the use of low vision aids can magnify the images to a level that allows the rod cells to identify details.
Age related macular degeneration (AMD) is the leading cause of legal blindness among adults over the age of 65 years of age. AMD is more common among smokers and those of Scandinavian descent or those with blond hair and blue eyes. It is thought that the reduced amount of pigment called melanin does not provide those with fair colored skin and eyes with sufficient protection from the harmful rays of the sun. For these reasons, it is strongly recommended that those with a family history of AMD stop smoking and wear protective filters when outdoors to filter the short wavelength solar radiation.
Dry AMD is the most common form of age related macular degeneration. It primarily affects the cone cells of the macular region and does not cause the leakage of blood or other fluid around the macula. The visual acuity tends to range from 20/70 to 20/200. The rate of progression of the disease is relatively slow. There is no medical treatment for dry AMD but vitamin therapy has been reported to slow the progression of the disease. Low vision aids and specialized glasses are very effective in improving reading sight, reducing problems with glare, and protecting the eyes from the harmful rays of the sun. Many patients with dry AMD are able to continue to drive with the use of specialized bioptic glasses.
Wet age related macular degeneration (WAMD) is a more complicated form of AMD in which the blood vessels under the macula leak and later grow abnormal new vessels. The leakage of blood under the macula causes swelling and the normally flat retina is elevated, causing straight lines to appear wavy and distorted. The visual acuity may be as good as 20/70 but may quickly deteriorate to 20/400 as the hemorrhages underneath the macula enlarge. Continued leakage of blood under the macula can cause blind spots in the central vision and patients may be forced to look off to the side in order to see details of objects more clearly.
Wet macular degeneration is treated with the use of specialized tests to determine the location of the hemorrhage. The use of fluorescein dye injected in the arm can determine the location of the hemorrhage and laser, photodynamic therapy, and other medications are used to stop the leakage of blood or to prevent the formation of additional blood vessels under the macula.
Juvenile macular degeneration is the term used to describe cases where macular degeneration affects the eyes of children and young adults There are many different forms of juvenile macular degeneration including Best’s disease, fundus flava maculata, cone degeneration, and Stargardt’s disease. Blurred distance and near sight, sensitivity to glare and bright light, blind spots in the central field of vision, and reduced depth perception are common symptoms. Similar to age related macular degeneration, there are no cures for these diseases but children and young adults respond extremely well to low vision rehabilitation.
Recommendations
The Dr. Bill Takeshita Fundation
c/o The Center for the Partially Sighted
12301 Wilshire Boulevard, Suite 600
Los Angeles, CA 90025
Phone: (310) 458-3501 · Fax: (310) 458-8179
Powered by PmWiki, Sinorca / skin originally by CarlosAB
Copyright © 2004-2008 www.DrBillFoundation.org - All Rights Reserved.
Page last modified August 04, 2007